Cargando…

Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas

Paragangliomas are rare neuroendocrine tumors that can vary in size and metabolic activity. We report a case of giant bilateral malignant retroperitoneal paragangliomas (PGL) in a patient with germline succinate dehydrogenase B (SDHB) mutation. This patient, who presented in an emaciated and debilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauss, David, Correa, Andres, Gong, Yulan, Karachristos, Andreas, Kutikov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649644/
https://www.ncbi.nlm.nih.gov/pubmed/34926161
http://dx.doi.org/10.1016/j.eucr.2021.101950
_version_ 1784611043589226496
author Strauss, David
Correa, Andres
Gong, Yulan
Karachristos, Andreas
Kutikov, Alexander
author_facet Strauss, David
Correa, Andres
Gong, Yulan
Karachristos, Andreas
Kutikov, Alexander
author_sort Strauss, David
collection PubMed
description Paragangliomas are rare neuroendocrine tumors that can vary in size and metabolic activity. We report a case of giant bilateral malignant retroperitoneal paragangliomas (PGL) in a patient with germline succinate dehydrogenase B (SDHB) mutation. This patient, who presented in an emaciated and debilitated state, was managed with adrenergic blockade followed by radical primary surgery. After being metabolically and radiographically disease free for 4 years, he underwent salvage resection for recurrent retroperitoneal disease and palliative radiation to a site of solidary vertebral metastasis. We review incidence and prognosis of metastatic PGL.
format Online
Article
Text
id pubmed-8649644
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86496442021-12-17 Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas Strauss, David Correa, Andres Gong, Yulan Karachristos, Andreas Kutikov, Alexander Urol Case Rep Oncology Paragangliomas are rare neuroendocrine tumors that can vary in size and metabolic activity. We report a case of giant bilateral malignant retroperitoneal paragangliomas (PGL) in a patient with germline succinate dehydrogenase B (SDHB) mutation. This patient, who presented in an emaciated and debilitated state, was managed with adrenergic blockade followed by radical primary surgery. After being metabolically and radiographically disease free for 4 years, he underwent salvage resection for recurrent retroperitoneal disease and palliative radiation to a site of solidary vertebral metastasis. We review incidence and prognosis of metastatic PGL. Elsevier 2021-11-26 /pmc/articles/PMC8649644/ /pubmed/34926161 http://dx.doi.org/10.1016/j.eucr.2021.101950 Text en Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Strauss, David
Correa, Andres
Gong, Yulan
Karachristos, Andreas
Kutikov, Alexander
Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
title Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
title_full Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
title_fullStr Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
title_full_unstemmed Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
title_short Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas
title_sort management of shdb positive patient with metastatic bilateral giant retroperitoneal paragangliomas
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649644/
https://www.ncbi.nlm.nih.gov/pubmed/34926161
http://dx.doi.org/10.1016/j.eucr.2021.101950
work_keys_str_mv AT straussdavid managementofshdbpositivepatientwithmetastaticbilateralgiantretroperitonealparagangliomas
AT correaandres managementofshdbpositivepatientwithmetastaticbilateralgiantretroperitonealparagangliomas
AT gongyulan managementofshdbpositivepatientwithmetastaticbilateralgiantretroperitonealparagangliomas
AT karachristosandreas managementofshdbpositivepatientwithmetastaticbilateralgiantretroperitonealparagangliomas
AT kutikovalexander managementofshdbpositivepatientwithmetastaticbilateralgiantretroperitonealparagangliomas